Head Roszdravnadzor Nikolai Yurhel sent an official letter to the head of Rospotrebnadzor Gennady Onishchenko, in which it notifies the issuing of state registration of the vaccine against the flu "Grifor."As recalled by the online resource medportal.ru, formerly head of the agency Onishchenko expressed doubts about the validity of the registration of this drug.
Document Nikolai Yurhel reported that the examination of the quality, effectiveness and safety of the vaccine was carried out in an accredited or approved by RZN organizations - Research Institute of Epidemiology and Microbiology.NFGamal.It is noted that the very examination was conducted in accordance with applicable Russian legislation.
Nikolai Yurhel emphasizes that the study vaccine "Grifor" became the first in the Russian practice of vaccine research, which was conducted with the participation of about 10 thousand volunteers.According to the head Roszdravnadzor, the results suggest a high efficacy and safety of the new medicine.
The letter also noted that the emergence of the domestic pharmaceutical market of the new vaccine will allow physicians to more effectively carry out prevention of influenza epidemic in the coming season.
remains to add that in the very near future Roszdravnadzor intends to bring this information to the heads of all regional health authorities, as well as the Office of Rospotrebnadzor subjects of the Russian Federation.